Cargando…

Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion

Dalbavancin is a lipoglycopeptide antibiotic with a prolonged half-life. A phase 1 study assessed dalbavancin levels in epithelial lining fluid (ELF) in 35 healthy adults using ELF bronchial microsampling up to 168 h after administration of 1,500 mg dalbavancin. The penetration of dalbavancin into E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rappo, Urania, Dunne, Michael W., Puttagunta, Sailaja, Baldassarre, James S., Su, Shengfang, Desai-Krieger, Daksha, Inoue, Megumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Clinical Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811436/ https://www.ncbi.nlm.nih.gov/pubmed/31501147 http://dx.doi.org/10.1128/AAC.01024-19

Ejemplares similares

Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials
por: Gonzalez, Pedro L., et al.
Publicado: (2021)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
por: Gonzalez, Pedro Luis, et al.
Publicado: (2018)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
por: Scoble, Patrick J., et al.
Publicado: (2015)

Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
por: Gonzalez, Pedro L., et al.
Publicado: (2021)

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
por: Rappo, Urania, et al.
Publicado: (2018)

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
por: Dunne, Michael W., et al.
Publicado: (2016)

Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
por: Dunne, Michael W, et al.
Publicado: (2015)

Necrotizing Fasciitis Within 72 hours After Presentation with Skin and Skin Structure Infection
por: Rappo, Urania, et al.
Publicado: (2020)

Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
por: Dunne, Michael W., et al.
Publicado: (2015)

266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

279. Dalbavancin for Bloodstream Infections and Endocarditis: Real-World Outcomes From the DRIVE Registry
por: Gonzalez, Pedro, et al.
Publicado: (2020)

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Obese Population
por: Georgiades, Benjamin, et al.
Publicado: (2017)

1660. Dalbavancin Utilization Registry Investigating Value and Effectiveness (DRIVE): Outcomes Report on Real-World Use
por: Jones, Bruce M, et al.
Publicado: (2022)

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Patients with Diabetes Mellitus
por: Nowak, Michael, et al.
Publicado: (2017)

DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum
por: Collins, Katharine A., et al.
Publicado: (2019)

Estradiol: micrograms or milligrams
por: Kirk, Jeremy M W, et al.
Publicado: (2016)

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial
por: Moscetti, Luca, et al.
Publicado: (2017)

1000. Antimicrobial Susceptibility of Gram-Positive Bacteria Isolated From Patients Hospitalized With Bacteremia in United States and European Medical Centers: Results From the International Dalbavancin Evaluation of Activity (IDEA) Program
por: Sader, Helio S, et al.
Publicado: (2018)

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials
por: Riccobene, Todd, et al.
Publicado: (2023)

Infusions of Digitalis in Heart Cases
Publicado: (1908)

The effects of age on sperm quality: an evaluation of 1,500 semen samples
por: Oliveira, João Batista A., et al.
Publicado: (2014)

398 Pharmacokinetics of dalbavancin (DAL) in bone and associated tissues in patients undergoing orthopedic surgical procedures
por: Baldassarre, James, et al.
Publicado: (2014)

Recent atmospheric drying in Siberia is not unprecedented over the last 1,500 years
por: Churakova Sidorova, O. V., et al.
Publicado: (2020)

Anesthesia considerations for robotic-assisted laparoscopic prostatectomy: a review of 1,500 cases
por: Danic, Michael J., et al.
Publicado: (2007)

ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins
por: Davenport, Emily R., et al.
Publicado: (2016)

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
por: Fraisse, Alain, et al.
Publicado: (2020)

Outcome of Patients With Esophageal Atresia and Very Low Birth Weight (≤ 1,500 g)
por: Ritz, Laura Antonia, et al.
Publicado: (2020)

Reductive aminations by imine reductases: from milligrams to tons
por: Gilio, Amelia K., et al.
Publicado: (2022)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
por: Turner, Nicholas A., et al.
Publicado: (2022)

Prematuros menores de 1,500 grs., evolución clínica y sus complicaciones : revisión bibliográfica /
por: Torres Sánchez, José Luis
Publicado: (1987)

Revised monthly energy generation estimates for 1,500 hydroelectric power plants in the United States
por: Turner, Sean W. D., et al.
Publicado: (2022)

1393. A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Subjects Under Fasting Conditions of Orally Administered Sulopenem Etzadroxil Alone or with Probenecid to Determine the Pharmacokinetics of Sulopenem
por: Dunne, Michael, et al.
Publicado: (2018)

1527. The Prevalence of Enterobacteriaceae (ENT) Resistant to All Major Classes of Oral Antibiotics from Outpatient Urine Cultures in the United States and Effect on Clinical Outcomes
por: Dunne, Michael, et al.
Publicado: (2018)

A Phylogeny of Birds Based on Over 1,500 Loci Collected by Target Enrichment and High-Throughput Sequencing
por: McCormack, John E., et al.
Publicado: (2013)

Comparison of three screening tests for autism in preterm children with birth weights less than 1,500 grams
por: Dudova, Iva, et al.
Publicado: (2014)

Differences of airborne and mural microorganisms in a 1,500-year-old Xu Xianxiu’s Tomb, Taiyuan, China
por: Liu, Jiangyun, et al.
Publicado: (2023)

Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
por: Boni, J P, et al.
Publicado: (2008)

Milligram Production and Biological Activity Characterization of the Human Chemokine Receptor CCR3
por: Wang, Mingqing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i26djpcda38fc5olio12qkfbm0